Latest News:
back to top

Latest News

NIHR ‘OK to ask’ campaign

This year’s National Institute for Health Research (NIHR) ‘OK to ask’ campaign will coincide with International Clinical Trials Day on 20 May. It is aimed at encouraging more patients or carers to ask about research …

Read full story »

Wales launches liver disease delivery plan

The Welsh Government has launched a national plan to tackle the increasing number of people suffering from liver disease which will be backed by Welsh Government funding. It comes as deaths from liver disease in …

Read full story »

Survey on provision of End of Life Care

The Care Quality Commission is currently undertaking a review of inequalities and variations in end of life care. They are looking to hear from a range of people about their experiences of care and so …

Read full story »

WCRF report on Liver Cancer

Today sees the publication of  a new report on Liver Cancer from the independent Expert Panel of the World Cancer Research Fund (WCRF) International Continuous Update Project (http://www.wcrf.org/int/research-we-fund/continuous-update-project-findings-reports/liver-cancer). This new report is based on a …

Read full story »

Your Liver – a special supplement in the press today

Todays Independent newspaper sees the publication of a special supplement on the Liver produced by Media Planet. The introduction, written by the Trust’s Chief Executive Andrew Langford, explains some key facts people may not know …

Read full story »

Heart of Gold foundation first industry summit

The Heart of Gold Foundation is a UK based charitable organisation devoted to the inclusion of patients in clinical research; an agenda that is shared wholeheartedly by the British Liver Trust and so Holly Dawson, …

Read full story »

New drugs and driving legislation come into force March 2015

A new offence of driving, attempting to drive, or being in charge of a vehicle, with certain controlled drugs in excess of specified limits, is expected to come into force on 2 March 2015. This …

Read full story »

NICE final guidance issued on new treatments for hepatitis C

The National Institute for Health and Care Excellence (NICE) has today published final guidance recommending sofosbuvir (Sovaldi, Gilead Sciences) and simeprevir (Olysio, Janssen) as treatment options for some people with chronic hepatitis C. The aims …

Read full story »

Study suggests Advagraf may have benefits for transplant patients

Results of a large observational study recently published in the American Journal of Transplantation (AJT) has demonstrated that early and sustained use of Advagraf, a once-daily immunosuppressant, offers a significant graft survival benefit in liver …

Read full story »

Liver Allocation Proposal feedback sought

The Liver Transplant Patient Consortium (LPTC), of which the Trust is a member, is asking for liver patient groups to provide feedback on new proposals for the allocation of livers for transplant. Feedback is requested …

Read full story »
Next Page »